Latest filing published 08 Jul 2025 for Rocket Pharmaceuticals, INC., €3,616.
Filing timeline
BuySaleInsider track record
Aaron Ondrey: trading record in brief
Aaron Ondrey has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Mirati Therapeutics, Inc. and Rocket Pharmaceuticals, Inc. Between 8 September 2023 and 3 July 2025, the trades on record add up to 9 filings.
On the market, this insider has only sold: 2 sales, €40k in total. The rest of the record consists of 4 share grants. Since January 2025: no purchases and 2 sales on the market.
The newest entry dates from 8 July 2025: an open-market sale of €3,616, in Rocket Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Aaron Ondrey
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,477 shares@ US$2.8829.2% of flowCommon StockSEC:0001140361-25-025244:0
- 7,489 shares@ US$5.29490.8% of flowCommon StockSEC:0001140361-25-012826:0
- 90,358 shares0Common StockSEC:0001140361-25-004293:0
- 46,781 shares0Common StockSEC:0001140361-24-017684:0
- 1,302 sharesCommon StockSEC:0001140361-24-003532:0
- 17,021 shares@ US$58.7576.3% of flowCommon StockSEC:0001628280-24-000279:0
- 8,412 shares@ US$35.6623.7% of flowCommon StockSEC:0001628280-23-032107:0
7 of 7 declarations
